- Form 8-K Item 8.01 covers slides from Virtual Investor Day.
- Phase 3 4WARD trial full enrollment expected Q4 2026, topline data Q1 2028.
- Neutral update outlining standard pipeline timelines without unexpected data surprises.
? Neutral AI Sentiment (+0.5 / 10)